Trump’s Antibody ‘Cure’ Will Be in Short Supply. your-feed-science, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Remdesivir (Drug), Clinical Trials, Hospitals, Antibodies, Elderly, Eli Lilly and Company, Food and Drug Administration, Regeneron Pharmaceuticals Inc, your-feed-healthcare